Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:grfs | https://www.glassdoor.com?employer_id=42397 | 42397 | Apr 28th, 2024 12:00AM | Open | Grifols | Open | Company - Public | Biotech & Pharmaceuticals | Barcelona, Spain | 1909 | 3.30 | 55% | 41% | 52% | 3.30 | 2.90 | 3.10 | 3.50 | 3.00 | 2.70 | 76.00 | 82.00 | 164.00 | 140.00 | 150.00 | 612.00 | 930.00 | 680.00 | 12.418% | 13.399% | 26.797% | 22.876% | 24.51% | 6.00 | 2246 | 0.61 | 0.18 | 0.21 | 0.77 | 0.08 | 0.06 | 0.01 | 0.07 | 0.02 | Open | Raimon Grifols and Victor Grifols Deu | Apr 28th, 2024 04:15PM | Apr 28th, 2024 04:15PM | Grifols | ||||||||
nasdaq:grfs | https://www.glassdoor.com?employer_id=42397 | 42397 | Apr 26th, 2024 12:00AM | Open | Grifols | Open | Company - Public | Biotech & Pharmaceuticals | Barcelona, Spain | 1909 | 3.30 | 55% | 41% | 52% | 3.30 | 2.90 | 3.10 | 3.50 | 3.00 | 2.70 | 76.00 | 82.00 | 165.00 | 140.00 | 151.00 | 614.00 | 930.00 | 680.00 | 12.378% | 13.355% | 26.873% | 22.801% | 24.593% | 6.00 | 2246 | 0.61 | 0.18 | 0.21 | 0.77 | 0.08 | 0.06 | 0.01 | 0.07 | 0.02 | Open | Raimon Grifols and Victor Grifols Deu | Apr 26th, 2024 08:01AM | Apr 26th, 2024 08:01AM | Grifols | ||||||||
nasdaq:grfs | https://www.glassdoor.com?employer_id=42397 | 42397 | Apr 25th, 2024 12:00AM | Open | Grifols | Open | Company - Public | Biotech & Pharmaceuticals | Barcelona, Spain | 1909 | 3.30 | 55% | 41% | 52% | 3.30 | 2.90 | 3.10 | 3.50 | 3.00 | 2.70 | 76.00 | 82.00 | 165.00 | 140.00 | 151.00 | 614.00 | 930.00 | 680.00 | 12.378% | 13.355% | 26.873% | 22.801% | 24.593% | 6.00 | 2246 | 0.61 | 0.18 | 0.21 | 0.77 | 0.08 | 0.06 | 0.01 | 0.07 | 0.02 | Open | Raimon Grifols and Victor Grifols Deu | Apr 25th, 2024 06:18PM | Apr 25th, 2024 06:18PM | Grifols | ||||||||
nasdaq:grfs | https://www.glassdoor.com?employer_id=42397 | 42397 | Apr 24th, 2024 12:00AM | Open | Grifols | Open | Company - Public | Biotech & Pharmaceuticals | Barcelona, Spain | 1909 | 3.30 | 55% | 41% | 52% | 3.30 | 2.90 | 3.10 | 3.50 | 3.00 | 2.70 | 76.00 | 82.00 | 166.00 | 141.00 | 151.00 | 616.00 | 930.00 | 680.00 | 12.338% | 13.312% | 26.948% | 22.89% | 24.513% | 6.00 | 2246 | 0.61 | 0.18 | 0.21 | 0.77 | 0.08 | 0.06 | 0.01 | 0.07 | 0.02 | Open | Raimon Grifols and Victor Grifols Deu | Apr 24th, 2024 10:45AM | Apr 24th, 2024 10:45AM | Grifols | ||||||||
nasdaq:grfs | https://www.glassdoor.com?employer_id=42397 | 42397 | Apr 23rd, 2024 12:00AM | Open | Grifols | Open | Company - Public | Biotech & Pharmaceuticals | Barcelona, Spain | 1909 | 3.30 | 55% | 41% | 52% | 3.30 | 2.90 | 3.10 | 3.50 | 3.00 | 2.70 | 76.00 | 82.00 | 166.00 | 141.00 | 151.00 | 616.00 | 930.00 | 680.00 | 12.338% | 13.312% | 26.948% | 22.89% | 24.513% | 6.00 | 2245 | 0.61 | 0.18 | 0.21 | 0.77 | 0.08 | 0.06 | 0.01 | 0.07 | 0.02 | Open | Raimon Grifols and Victor Grifols Deu | Apr 23rd, 2024 04:19PM | Apr 23rd, 2024 04:19PM | Grifols | ||||||||
nasdaq:grfs | https://www.glassdoor.com?employer_id=42397 | 42397 | Apr 21st, 2024 12:00AM | Open | Grifols | Open | Company - Public | Biotech & Pharmaceuticals | Barcelona, Spain | 1909 | 3.30 | 54% | 41% | 53% | 3.40 | 2.90 | 3.10 | 3.50 | 3.10 | 2.70 | 76.00 | 81.00 | 166.00 | 139.00 | 150.00 | 612.00 | 928.00 | 679.00 | 12.418% | 13.235% | 27.124% | 22.712% | 24.51% | 6.00 | 2242 | 0.60 | 0.18 | 0.21 | 0.77 | 0.08 | 0.06 | 0.01 | 0.07 | 0.02 | Open | Raimon Grifols and Victor Grifols Deu | Apr 21st, 2024 04:21PM | Apr 21st, 2024 04:21PM | Grifols | ||||||||
nasdaq:grfs | https://www.glassdoor.com?employer_id=42397 | 42397 | Apr 20th, 2024 12:00AM | Open | Grifols | Open | Company - Public | Biotech & Pharmaceuticals | Barcelona, Spain | 1909 | 3.30 | 54% | 41% | 53% | 3.40 | 2.90 | 3.10 | 3.50 | 3.10 | 2.70 | 76.00 | 82.00 | 166.00 | 139.00 | 150.00 | 613.00 | 928.00 | 679.00 | 12.398% | 13.377% | 27.08% | 22.675% | 24.47% | 6.00 | 2242 | 0.60 | 0.18 | 0.21 | 0.77 | 0.08 | 0.06 | 0.01 | 0.07 | 0.02 | Open | Raimon Grifols and Victor Grifols Deu | Apr 20th, 2024 04:37PM | Apr 20th, 2024 04:37PM | Grifols | ||||||||
nasdaq:grfs | https://www.glassdoor.com?employer_id=42397 | 42397 | Apr 19th, 2024 12:00AM | Open | Grifols | Open | Company - Public | Biotech & Pharmaceuticals | Barcelona, Spain | 1909 | 3.30 | 54% | 41% | 53% | 3.40 | 2.90 | 3.10 | 3.50 | 3.10 | 2.70 | 76.00 | 82.00 | 168.00 | 140.00 | 151.00 | 617.00 | 928.00 | 679.00 | 12.318% | 13.29% | 27.229% | 22.69% | 24.473% | 6.00 | 2241 | 0.60 | 0.18 | 0.21 | 0.77 | 0.08 | 0.06 | 0.01 | 0.07 | 0.02 | Open | Raimon Grifols and Victor Grifols Deu | Apr 19th, 2024 07:33AM | Apr 19th, 2024 07:33AM | Grifols | ||||||||
nasdaq:grfs | https://www.glassdoor.com?employer_id=42397 | 42397 | Apr 18th, 2024 12:00AM | Open | Grifols | Open | Company - Public | Biotech & Pharmaceuticals | Barcelona, Spain | 1909 | 3.30 | 54% | 41% | 53% | 3.40 | 2.90 | 3.10 | 3.50 | 3.10 | 2.70 | 76.00 | 82.00 | 168.00 | 140.00 | 151.00 | 617.00 | 928.00 | 679.00 | 12.318% | 13.29% | 27.229% | 22.69% | 24.473% | 6.00 | 2240 | 0.60 | 0.18 | 0.21 | 0.77 | 0.08 | 0.06 | 0.01 | 0.07 | 0.02 | Open | Raimon Grifols and Victor Grifols Deu | Apr 18th, 2024 05:56PM | Apr 18th, 2024 05:56PM | Grifols | ||||||||
nasdaq:grfs | https://www.glassdoor.com?employer_id=42397 | 42397 | Apr 17th, 2024 12:00AM | Open | Grifols | Open | Company - Public | Biotech & Pharmaceuticals | Barcelona, Spain | 1909 | 3.30 | 54% | 41% | 53% | 3.40 | 2.90 | 3.10 | 3.50 | 3.10 | 2.70 | 76.00 | 82.00 | 167.00 | 140.00 | 151.00 | 616.00 | 928.00 | 679.00 | 12.338% | 13.312% | 27.11% | 22.727% | 24.513% | 6.00 | 2238 | 0.60 | 0.18 | 0.21 | 0.77 | 0.08 | 0.06 | 0.01 | 0.07 | 0.02 | Open | Raimon Grifols and Victor Grifols Deu | Apr 17th, 2024 02:23PM | Apr 17th, 2024 02:23PM | Grifols |